Enveric Biosciences (ENVB) Total Non-Current Liabilities (2015 - 2023)
Enveric Biosciences (ENVB) posted Total Non-Current Liabilities of $4.21 million for Q2 2023, up 15.6% from $3.64 million a year earlier.
Powered by 
Analysis
Enveric Biosciences (ENVB) Total Non-Current Liabilities (2015 - 2023) Analysis & Trends
At the end of FY2021, Enveric Biosciences' Total Non-Current Liabilities came in at $1.68 million.
- Annual Total Non-Current Liabilities shows a five-year compound annual growth rate of -35.6% (FY2016 to FY2021).
- In prior years, Enveric Biosciences' Total Non-Current Liabilities was $1.17 million in FY2019 (-72.1%), $4.19 million in FY2018 (+76.0%) and $2.38 million in FY2017 (-84.3%).
- Quarterly Total Non-Current Liabilities has run from a low of $230,377 in Q2 2019 to a high of $11.22 million in Q3 2021 over five years.
- On a year-over-year basis, Total Non-Current Liabilities increased in three of the last four quarters, with growth averaging 242.3%.
- The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q1 2022, with growth of 800.2%; the weakest was Q2 2019, with a decline of 89.4%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.24 Bn | 1,102.83 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 616.05 Bn | 534.58 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 500.90 Bn | 474.01 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 367.17 Bn | 321.54 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.35 Bn | 235.03 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 235.77 Bn | 191.17 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 190.70 Bn | 164.90 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 169.35 Bn | 115.99 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Enveric Biosciences | 6.02 Mn | -15.62 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 4.21 Mn |
| Sep 30, 2022 | 4.66 Mn |
| Jun 30, 2022 | 3.64 Mn |
| Mar 31, 2022 | 5.64 Mn |
| Dec 31, 2021 | 1.68 Mn |
| Sep 30, 2021 | 11.22 Mn |
| Jun 30, 2021 | 1.17 Mn |
| Mar 31, 2021 | 626,947.00 |
| Sep 30, 2020 | 825,248.00 |
| Jun 30, 2020 | 1.86 Mn |
| Dec 31, 2019 | 1.17 Mn |
| Sep 30, 2019 | 4.45 Mn |
| Jun 30, 2019 | 230,377.00 |
| Mar 31, 2019 | 4.64 Mn |
| Dec 31, 2018 | 4.19 Mn |
| Sep 30, 2018 | 2.94 Mn |
| Jun 30, 2018 | 2.18 Mn |
| Mar 31, 2018 | 2.28 Mn |
| Dec 31, 2017 | 2.38 Mn |
| Sep 30, 2017 | 3.43 Mn |
API Access
Enveric Biosciences Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ENVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "ENVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ENVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();